Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the company will encore data from the BEACON Phase 1/2 ...
21h
Medexus will target a commercial launch in 1H CY2025; potential for annual product-level revenue to exceed US$100 million ...
Hosted on MSN14h
FDA Approves Treosulfan as Part of AML/MDS Conditioning RegimenThe FDA approved treosulfan (Grafapex) with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell ...
JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy ...
Sanofi (NASDAQ:SNY) has received EU regulatory approval for its drug Sarclisa for the treatment of newly diagnosed multiple myeloma patients. The drug was approved for use in combination with a ...
Sanofi’s Sarclisa has been approved by the European Union as the first anti-CD38 therapy in combination with VRd to treat adult patients with newly diagnosed multiple myeloma who are ineligible for ...
Days before a mid-January flight to Antigua, Guatemala, the Dallas lifestyle blogger hovered over her suitcase like Regina ...
Sanofi’s Sarclisa has been approved by the European Union as the first anti-CD38 therapy in combination with VRd to treat adult patients with newly diagnosed multiple myeloma who are ineligible for ...
SAN FRANCISCO, January 16, 2025--Stem, Inc. (NYSE: STEM), a global leader in artificial intelligence (AI)-enabled clean energy software and services, today announced that its Board of Directors ...
Humans are the only mammals with long hair on their heads. Scientists look into what drives this unique feature.
Service specifications are important in clearly defining the standards of care expected from organisations funded by NHS England to provide specialised care. The specifications have been developed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback